Donald D. Sin MD, FRCP, MPH

Don Sin received his medical degree at University of Alberta, Edmonton, Canada (1991), completed medical residency in general medicine and respiratory medicine at University of Alberta (in 1995) and received a Master’s of Public Health degree at Harvard University, Boston, USA (1997). He was recruited to the University of British Columbia (UBC) in 2004 as a Canada Research Chair in COPD and a GlaxoSmithKline/St. Paul’s Foundation Professor of COPD.
He is currently a staff respirologist at St. Paul’s Hospital and the head of Respiratory Medicine at Providence Health Care in Vancouver. According to Expertscape, he is the #1 medical expert in COPD across North America and 2nd in the world (http://www.expertscape.com/ex/copd/p/earth). He has published 300 peer-reviewed articles and has written numerous editorials and book chapters. He has published in the Lancet, JAMA, BMJ, and New England Journal of Medicine and Lancet. He serves on the scientific committee of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) initiative (2009-present).
His main research focus is to discover novel biomarkers to improve the care and diagnosis of patients with COPD, which currently is the 3rd leading cause of death worldwide. He serves as an editorial board member of several respiratory journals including the American Journal of Respiratory and Critical Care Medicine, Chest, Journal of COPD Foundation and European Respiratory Journal. He is an associate editor of Thorax.